How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Business Services · Forecast 2027–2033
70% Lysine Market
- By Product Form: Feed Grade Lysine, Pharmaceutical Grade Lysine, Food Grade Lysine, Industrial Grade Lysine
- By Application: Animal Feed Additives, Food and Beverage Industry, Pharmaceuticals, Nutritional Supplements, Cosmetics
- By Production Process: Fermentation-derived Lysine, Chemical Synthesis Lysine
- By End-user Industry: Poultry Feed, Swine Feed, Aquaculture Feed, Ruminant Feed
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Feed Grade Lysine leads By Product Form at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 270 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.161 →
- 11 Company Profiles 15 players: SWOT & benchmarking p.169 →
Full report · locked preview
Everything inside the 70% Lysine Market report
A complete, evidence-based study - 11 chapters and 113 sections covering market size, segmentation across 4 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Product Form 4
Application 5
Production Process 2
End-user Industry 4
Companies profiled
ADM (Archer Daniels Midland Company)
CJ CheilJedang Corporation
Evonik Industries AG
Ajinomoto Co. Inc.
Fufeng Group
Shandong Hongda Biotechnology Co. Ltd.
Meihua Holdings Group Co. Ltd.
Novus International Inc.
Daesang Corporation
Jiangsu Boli Bioproducts Co. Ltd.
Zhejiang NHU Co. Ltd.
Henan Tianguan Group Co. Ltd.
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →ADM (Archer Daniels Midland Company)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →CJ CheilJedang Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Evonik Industries AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Ajinomoto Co. Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Fufeng Group
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Shandong Hongda Biotechnology Co. Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Meihua Holdings Group Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Novus International Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Daesang Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Jiangsu Boli Bioproducts Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Zhejiang NHU Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Henan Tianguan Group Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Shandong Longlive Bio-technology Co. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Shandong Luwei Pharmaceutical Co. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Shandong Yuwang Industrial Co. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$10,028M by 2033 · 8.2% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Feed Grade Lysine46.2
- Pharmaceutical Grade Lysine12.0
- Food Grade Lysine22.3
- Industrial Grade Lysine19.5
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,755M → $3,563M · 9.3%
Europe$1,223M → $2,276M · 8.1%
Asia Pacific$1,117M → $2,324M · 9.6%
Latin America$691.4M → $1,433M · 9.5%
Middle East and Africa$531.9M → $1,058M · 9.0%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →8.212026
8.222027
8.232028
8.232029
8.262030
8.262031
8.272032
8.282033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- ADM (Archer Daniels Midland Company)23.1
- CJ CheilJedang Corporation18.1
- Evonik Industries AG7.2
- Ajinomoto Co. Inc.10.7
- Fufeng Group3.9
- Shandong Hongda Biotechnology Co. Ltd.9.0
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Product Form30.8%
Application26.9%
Production Process17.4%
End-user Industry24.8%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America33.4
- Europe21.4
- Asia Pacific21.8
- Latin America13.4
- Middle East and Africa9.9
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| ADM (Archer Daniels Midland Company) | 84 | 93 | 98 | 79 | 91 | 79 | 87 |
| CJ CheilJedang Corporation | 81 | 82 | 82 | 86 | 90 | 78 | 83 |
| Evonik Industries AG | 79 | 67 | 77 | 86 | 72 | 68 | 75 |
| Ajinomoto Co. Inc. | 59 | 58 | 77 | 61 | 70 | 65 | 65 |
| Fufeng Group | 66 | 63 | 64 | 69 | 73 | 56 | 65 |
| Shandong Hongda Biotechnology Co. Ltd. | 50 | 59 | 61 | 62 | 53 | 62 | 58 |
| Meihua Holdings Group Co. Ltd. | 55 | 55 | 64 | 42 | 49 | 65 | 55 |
| Novus International Inc. | 46 | 60 | 46 | 42 | 51 | 45 | 48 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- ADM (Archer Daniels Midland Company)
- CJ CheilJedang Corporation
- Evonik Industries AG
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| ADM (Archer Daniels Midland Company) | ◐ | ✓ | ✓ | ✓ | ◐ | ✓ |
| CJ CheilJedang Corporation | ✓ | ✓ | ◐ | ✓ | ◐ | ◐ |
| Evonik Industries AG | ◐ | ◐ | ✓ | ✓ | ◐ | − |
| Ajinomoto Co. Inc. | ◐ | ◐ | ✓ | ◐ | ◐ | ◐ |
| Fufeng Group | ◐ | ◐ | − | ◐ | ◐ | ◐ |
| Shandong Hongda Biotechnology Co. Ltd. | − | − | ◐ | ◐ | ◐ | ◐ |
| Meihua Holdings Group Co. Ltd. | ◐ | − | − | − | ◐ | − |
| Novus International Inc. | − | ◐ | − | − | ◐ | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1ADM (Archer Daniels Midland Company)87
2CJ CheilJedang Corporation83
3Evonik Industries AG75
4Ajinomoto Co. Inc.65
5Fufeng Group65
6Shandong Hongda Biotechnology Co. Ltd.58
7Meihua Holdings Group Co. Ltd.55
8Novus International Inc.48
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
ADM (Archer Daniels Midland Company)CJ CheilJedang Corporation
Challenger1
Strong scale, closing on the leaders.
Evonik Industries AG
Contender3
Focused players with pockets of strength.
Ajinomoto Co. Inc.Fufeng GroupShandong Hongda Biotechnology Co. Ltd.
Niche2
Specialists in a single segment or region.
Meihua Holdings Group Co. Ltd.Novus International Inc.
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Product Form in North America, then scale across 70% Lysine Market — a $313M beachhead inside a $4.97B market.
Beachhead (SOM)$313Mobtainable near-term
Serviceable (SAM)$2.00Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion92 fit
Feed Grade Lysine
Best fit — highest urgency & budget in Product Form.
Economic buyer75 fit
Pharmaceutical Grade Lysine
Strong fit — clear ROI and a fast path to value.
End user65 fit
Food Grade Lysine
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Product Form in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Application & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Production Process
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales42%
Partner / channel29%
Digital / self-serve21%
Marketplaces8%
Positioning & messaging
§GTM 2 · p.194 →For Product Form leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win 70% Lysine Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified43%
Sales qualified24%
Evaluation12%
Closed-won6%
$12.2KCAC
$45KLTV
3.7:1LTV : CAC
< 5 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
70% Lysine Market is a high-growth opportunity — $10.7B by 2033, compounding at 11.1%.
TAM · 2025$4.63Btoday
TAM · 2033$10.7Bforecast
CAGR11.1%2027–2033
Cumulative$65.8Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$10.7BTotal addressable market
SAM$3.94BServiceable available market
SOM$741MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →11.1% CAGR
Demand compounds through 2033, outpacing GDP across Product Form.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Product Form moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$10.7BLarge & growingTAM by 2033 at 11.1% CAGR
$3.94BServiceable nowreachable with today’s model
$741MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$8.38BBear7.2% CAGR
$10.7BBase11.1% CAGR
$13.7BBull14.7% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Application optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
70% Lysine Market — a $6.97B market by 2033. Plan: grow share from 6.9% to 12.7%.
Market size · 2033$6.97Btotal addressable
Market CAGR3.5%2027–2033
Target share12.7%from 6.9% today
Revenue ambition$885Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 6.9% | 12.7% | On track |
| Revenue | $508M | $885M | Behind |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Ahead |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | On track |
| Gross margin | 31.8% | 40.2% | Ahead |
| Customer retention | 88.9% | 94.7% | At risk |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Product Form
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Application capability
A defensible second engine — invest in Application to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Product Form share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Application
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $110M capacity & capability investment
- Greenlight bolt-on M&A in Application
- Authorise North America expansion plan
- Fund R&D program for Product Form leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAt risk
- Competitive share lossOn track
- Input-cost & supply riskBehind
- Regulatory / policy changeOn track
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the 70% Lysine Market conversation — a $2.93B market you can size, segment and defend in minutes.
Market size · 2033$2.93Btotal opportunity
Growth3.8%CAGR to 2033
Addressable buyers1,699+accounts in scope
Typical ROI6.3×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Product Form
Goal Grow share in Product Form
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →6.3×return on cost, year one
< 3 mopayback period
$75K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
ADM (Archer Daniels Midland Company)CJ CheilJedang CorporationEvonik Industries AGAjinomoto Co. Inc.Fufeng GroupShandong Hongda Biotechnology Co. Ltd.Meihua Holdings Group Co. Ltd.Novus International Inc.+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your 70% Lysine Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
70% Lysine Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Business Services · scroll →7000 Series Aluminum Billets and Aluminum Alloy Market
Market size, share, segmentation and regional forecast.
$2.9B market · 2025 base year
View report700-750 Mhz Nuclear Magnetic Resonance Spectrometer (Nmr) Market
Market size, share, segmentation and regional forecast.
$2.5B market · 2025 base year
View report75 High-Carbon Ferromanganese Market
Market size, share, segmentation and regional forecast.
$2.4B market · 2025 base year
View report75 Ohm Coax Cable Market
Market size, share, segmentation and regional forecast.
$4.4B market · 2025 base year
View report75V Module Series of Ultracapacitors Market
Market size, share, segmentation and regional forecast.
$4.9B market · 2025 base year
View report77 GHz Automotive Millimeter Wave Radar PCB Market
Market size, share, segmentation and regional forecast.
$3.5B market · 2025 base year
View report7A Type A Drum Market
Market size, share, segmentation and regional forecast.
$3.5B market · 2025 base year
View report7-AAD Market
Market size, share, segmentation and regional forecast.
$5.4B market · 2025 base year
View report7Al-4Mo Titanium Market
Market size, share, segmentation and regional forecast.
$1.8B market · 2025 base year
View report7-Amino Cephalosporanic Acid (API) Market
Market size, share, segmentation and regional forecast.
$5.8B market · 2025 base year
View report7-Avca Market
Market size, share, segmentation and regional forecast.
$3.9B market · 2025 base year
View report7-Axis Articulated Arm Measuring Instrument Market
Market size, share, segmentation and regional forecast.
$1.8B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.